ABOUT INDEXING BOARD ARCHIVES AUTHOR GUIDELINES SUBMIT PAPER AUTHOR'S PAGE NEWS, EVENTS CONTACT
REVISTA DE CHIMIE
Cite as: Rev. Chim.
https://doi.org/10.37358/Rev.Chim.1949

OSIM Nr. R102355
ISSN Online 2668-8212
ISSN Print: 1582-9049
ISSN-L: 1582-9049

REVISTA DE CHIMIE Latest Issue

LATEST ISSUE >>>

   Volume 77, 2026
   Volume 76, 2025
   Volume 75, 2024
   Volume 74, 2023
   Volume 73, 2022
   Volume 72, 2021
   Volume 71, 2020
   Volume 70, 2019
   Volume 69, 2018
   Volume 68, 2017
   Volume 67, 2016
   Volume 66, 2015
   Volume 65, 2014
   Volume 64, 2013
   Volume 63, 2012
   Volume 62, 2011
   Volume 61, 2010
   Volume 60, 2009
   Volume 59, 2008
   Volume 58, 2007
 
<<<< back

Revista de Chimie (Rev. Chim.), Year 2018, Volume 69, Issue 3, 587-590

https://doi.org/10.37358/RC.18.3.6155

Dragos Cristian Stefanescu, Razvan Hainarosie, Viorel Zainea, Anca Pantea Stoian, Cornelia Nitipir, Bogdan Mihai Marinescu, Dan Corneci

Intratympanic Dexamethasone as First-Line Treatment for Selected Patients With Hearing Loss

Abstract:

There is no consensus among ENT (ear, nose and throat) physicians on the causes, diagnosis and especially therapeutic approach in sensorineural hearing loss (SSHL). The present paper describes our experience with intratympanic dexamethasone injection as initial treatment for selected patients with the sudden sensorineural hearing loss. The results obtained were fully encouraging. The sustained and coherent approaches of the national ENT society through his section of otoneurology, can lead to a diagnostic and therapeutic consensus in the sensorineural hearing loss. Further, the National Health Insurance House must introduce in the methodological norms the therapeutic variants and the concrete conditions for their realisation, in order to have a common medical practice.
Keywords:
intratympanic injection; dexamethasone; sudden sensorineural hearing loss; ENT

Issue: 2018, Volume 69, Issue 3
Pages: 587-590
Publication date: 2018/4/15
https://doi.org/10.37358/RC.18.3.6155
download pdf   Download Pdf Article
Creative Commons License
This article is published under the Creative Commons Attribution 4.0 International License
Citation Styles
Cite this article as:
STEFANESCU, D.C., HAINAROSIE, R., ZAINEA, V., STOIAN, A.P., NITIPIR, C., MARINESCU, B.M., CORNECI, D., Intratympanic Dexamethasone as First-Line Treatment for Selected Patients With Hearing Loss, Rev. Chim., 69(3), 2018, 587-590.

Vancouver
Stefanescu DC, Hainarosie R, Zainea V, Stoian AP, Nitipir C, Marinescu BM, Corneci D. Intratympanic Dexamethasone as First-Line Treatment for Selected Patients With Hearing Loss. Rev. Chim.[internet]. 2018 Mar;69(3):587-590. Available from: https://doi.org/10.37358/RC.18.3.6155


APA 6th edition
Stefanescu, D.C., Hainarosie, R., Zainea, V., Stoian, A.P., Nitipir, C., Marinescu, B.M. & Corneci, D. (2018). Intratympanic Dexamethasone as First-Line Treatment for Selected Patients With Hearing Loss. Revista de Chimie, 69(3), 587-590. https://doi.org/10.37358/RC.18.3.6155


Harvard
Stefanescu, D.C., Hainarosie, R., Zainea, V., Stoian, A.P., Nitipir, C., Marinescu, B.M., Corneci, D. (2018). 'Intratympanic Dexamethasone as First-Line Treatment for Selected Patients With Hearing Loss', Revista de Chimie, 69(3), pp. 587-590. https://doi.org/10.37358/RC.18.3.6155


IEEE
D.C. Stefanescu, R. Hainarosie, V. Zainea, A.P. Stoian, C. Nitipir, B.M. Marinescu, D. Corneci, "Intratympanic Dexamethasone as First-Line Treatment for Selected Patients With Hearing Loss". Revista de Chimie, vol. 69, no. 3, pp. 587-590, 2018. [online]. https://doi.org/10.37358/RC.18.3.6155


Text
Dragos Cristian Stefanescu, Razvan Hainarosie, Viorel Zainea, Anca Pantea Stoian, Cornelia Nitipir, Bogdan Mihai Marinescu, Dan Corneci,
Intratympanic Dexamethasone as First-Line Treatment for Selected Patients With Hearing Loss,
Revista de Chimie,
Volume 69, Issue 3,
2018,
Pages 587-590,
ISSN 2668-8212,
https://doi.org/10.37358/RC.18.3.6155.
(https://revistadechimie.ro/Articles.asp?ID=6155)
Keywords: intratympanic injection; dexamethasone; sudden sensorineural hearing loss; ENT


RIS
TY - JOUR
T1 - Intratympanic Dexamethasone as First-Line Treatment for Selected Patients With Hearing Loss
A1 - Stefanescu, Dragos Cristian
A2 - Hainarosie, Razvan
A3 - Zainea, Viorel
A4 - Stoian, Anca Pantea
A5 - Nitipir, Cornelia
A6 - Marinescu, Bogdan Mihai
A7 - Corneci, Dan
JF - Revista de Chimie
JO - Rev. Chim.
PB - Revista de Chimie SRL
SN - 2668-8212
Y1 - 2018
VL - 69
IS - 3
SP - 587
EP - 590
UR - https://doi.org/10.37358/RC.18.3.6155
KW - intratympanic injection
KW - dexamethasone
KW - sudden sensorineural hearing loss
KW - ENT
ER -


BibTex
@article{RevCh2018P587,
author = {Stefanescu Dragos Cristian and Hainarosie Razvan and Zainea Viorel and Stoian Anca Pantea and Nitipir Cornelia and Marinescu Bogdan Mihai and Corneci Dan},
title = {Intratympanic Dexamethasone as First-Line Treatment for Selected Patients With Hearing Loss},
journal = {Revista de Chimie},
volume = {69},
number = {3},
pages = {587-590},
year = {2018},
issn = {2668-8212},
doi = {https://doi.org/10.37358/RC.18.3.6155},
url = {https://revistadechimie.ro/Articles.asp?ID=6155}
}
 
<<<< back
 
PUBLISHING SECTION
Author Guidelines
 * Paper Drafting
 * Paper Template
 * Ethical Statement
 * Paper Submission
Ghidul Autorului (ro)
Submit Paper
Author's Page
Publishing Ethics
Peer Review Process
Open Access & Archiving Policy
 Search Authors
 LATEST NEWS
REvista de Chimie NUMAR OMAGIAL PETRU PONI.. detalii
REvista de Chimie Revista de Chimie - 70 de ani de aparitie neintrerupta.. detalii
dictionar English-Romanian Dictionary for Mechanical Engineering
(download pdf)
  News, Events
Crossref Member Badge
 DOI  logo
 Gold Open Access | Source=http://www.plos.org/  | Author=art designer at PLoS
Creative Commons License
 Conferences of Contemporary
 Chemistry
 Biblioteca Chimiei
 Materiale Plastice